Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit G Pandya

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|August 21, 2023
Clinician-reported outcome measures for the assessment of vitiligo: A scoping reviewNanja van Geel, Jolien Duponselle, Liesbeth Delbaere, et al.
Science Translational Medicine|July 20, 2018
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligoJillian M Richmond, James P Strassner, Lucio Zapata, et al.
Journal of the American Academy of Dermatology|August 25, 2024
Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantationIltefat H Hamzavi, Anand K Ganesan, Bassel H Mahmoud, et al.
Journal of the American Academy of Dermatology|March 30, 2025
Autologous cell harvesting device provides repigmentation and improves quality-of-life for patients with stable vitiligo lesions in a large and diverse patient populationAmit G Pandya, Bassel H Mahmoud, Richard H Huggins, et al.
Science Translational Medicine|September 13, 2021
scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T<sub>reg</sub> functionKyle J Gellatly, James P Strassner, Kingsley Essien, et al.
Journal of the American Academy of Dermatology|November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trialKhaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.
Archives of Dermatological Research|March 25, 2023
Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey studyNicoline F Post, Noah X Van Broekhoven, Annelies Lommerts, et al.
Pediatric Dermatology|October 20, 2022
Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in Spanish-speaking Latin American pediatric patients in the United States with atopic dermatitis: A randomized, controlled, evaluator-blinded studyHenry W Chen, Emily E Limmer, Adrienne K Joseph, et al.
The British Journal of Dermatology|August 24, 2023
Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithmQuentin Marin Dit Bertoud, Clémence Bertold, Khaled Ezzedine, et al.
JAMA Dermatology|October 17, 2012
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoidesStuart R Lessin, Madeleine Duvic, Joan Guitart, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Journal of the European Academy of Dermatology and Venereology : JEADV|August 21, 2023
Clinician-reported outcome measures for the assessment of vitiligo: A scoping reviewNanja van Geel, Jolien Duponselle, Liesbeth Delbaere, et al.
Science Translational Medicine|July 20, 2018
Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligoJillian M Richmond, James P Strassner, Lucio Zapata, et al.
Journal of the American Academy of Dermatology|August 25, 2024
Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantationIltefat H Hamzavi, Anand K Ganesan, Bassel H Mahmoud, et al.
Journal of the American Academy of Dermatology|March 30, 2025
Autologous cell harvesting device provides repigmentation and improves quality-of-life for patients with stable vitiligo lesions in a large and diverse patient populationAmit G Pandya, Bassel H Mahmoud, Richard H Huggins, et al.
Science Translational Medicine|September 13, 2021
scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T<sub>reg</sub> functionKyle J Gellatly, James P Strassner, Kingsley Essien, et al.
Journal of the American Academy of Dermatology|November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trialKhaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.
Archives of Dermatological Research|March 25, 2023
Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey studyNicoline F Post, Noah X Van Broekhoven, Annelies Lommerts, et al.
Pediatric Dermatology|October 20, 2022
Efficacy of a lay community health worker (promotoras de salud) program to improve adherence to emollients in Spanish-speaking Latin American pediatric patients in the United States with atopic dermatitis: A randomized, controlled, evaluator-blinded studyHenry W Chen, Emily E Limmer, Adrienne K Joseph, et al.
The British Journal of Dermatology|August 24, 2023
Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithmQuentin Marin Dit Bertoud, Clémence Bertold, Khaled Ezzedine, et al.
JAMA Dermatology|October 17, 2012
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoidesStuart R Lessin, Madeleine Duvic, Joan Guitart, et al.
Pageof 15